Latest News in the pharma Industry

Biopharma News

Shire to Acquire NPS Pharma as Further Step in Building a Leading Biotech

Shire to Acquire NPS Pharma as Further Step in Building a Leading Biotech

14 Jan 2015

Read more 
Hospira Submits New Biologics License Application to FDA for Proposed Epoetin Alfa Biosimilar

Hospira Submits New Biologics License Application to FDA for Proposed Epoetin Alfa Biosimilar

13 Jan 2015

Read more 
Sandoz Biosimilar Filgrastim Recommended for Approval by FDA Oncologic Drugs Advisory Committee

Sandoz Biosimilar Filgrastim Recommended for Approval by FDA Oncologic Drugs Advisory Committee

9 Jan 2015

Read more 
Sartorius to Sell Its Industrial Technologies Division to Minebea

Sartorius to Sell Its Industrial Technologies Division to Minebea

23 Dec 2014

Read more 
Selecta and Skolkovo Foundation Collaboration to Develop a Synthetic Vaccine Particle

Selecta and Skolkovo Foundation Collaboration to Develop a Synthetic Vaccine Particle

23 Dec 2014

Read more 
FUJIFILM Completes Acquisition of Kalon Biotherapeutics

FUJIFILM Completes Acquisition of Kalon Biotherapeutics

19 Dec 2014

Read more 
Stem Cell Therapies Gathering Momentum but Significant Challenges Remain

Stem Cell Therapies Gathering Momentum but Significant Challenges Remain

10 Dec 2014

Read more 
Phase III Data Shows Sandoz' Investigational Biosimilar filgrastim has Similar Safety and Efficacy as Amgen's Neupogen

Phase III Data Shows Sandoz' Investigational Biosimilar filgrastim has Similar Safety and Efficacy as Amgen's Neupogen

9 Dec 2014

Read more 
Horizon Discovery Group Plc Launches Gene-Engineered Bioproduction Cell Line with Flexible Licensing Model

Horizon Discovery Group Plc Launches Gene-Engineered Bioproduction Cell Line with Flexible Licensing Model

8 Dec 2014

Read more 
Stelis Biopharma Begins Construction of Multiproduct Biologics Facility at Bioxcell Biotechnology Park, Malaysia

Stelis Biopharma Begins Construction of Multiproduct Biologics Facility at Bioxcell Biotechnology Park, Malaysia

8 Dec 2014

Read more 
Catalent Announces Collaboration with Valerion Therapeutics

Catalent Announces Collaboration with Valerion Therapeutics

4 Dec 2014

Read more 
US Sales of Sanofi/Regeneron’s Dupilumab for Atopic Dermatitis Could Exceed $1.3 Billion by 2022

US Sales of Sanofi/Regeneron’s Dupilumab for Atopic Dermatitis Could Exceed $1.3 Billion by 2022

4 Dec 2014

Read more